TR201005900A1 - Geliştirilmiş stabiliteye sahip prasugrel granülleri. - Google Patents
Geliştirilmiş stabiliteye sahip prasugrel granülleri.Info
- Publication number
- TR201005900A1 TR201005900A1 TR2010/05900A TR201005900A TR201005900A1 TR 201005900 A1 TR201005900 A1 TR 201005900A1 TR 2010/05900 A TR2010/05900 A TR 2010/05900A TR 201005900 A TR201005900 A TR 201005900A TR 201005900 A1 TR201005900 A1 TR 201005900A1
- Authority
- TR
- Turkey
- Prior art keywords
- granules
- prasugrel
- improved stability
- coating layer
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Buluş, prasugrel hidroklorür içeren farmasötik granuller ile ılgılı olup, bahsedilen granullerin, pulluları içeren en az bir kaplama tabakasına sahip olması ile karaktenze edilmektedir.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/05900A TR201005900A1 (tr) | 2010-07-19 | 2010-07-19 | Geliştirilmiş stabiliteye sahip prasugrel granülleri. |
TR2010/07926A TR201007926A1 (tr) | 2010-07-19 | 2010-09-29 | Prasugrel tablet formülasyonları. |
ES11174384.5T ES2467934T3 (es) | 2010-07-19 | 2011-07-18 | Gránulos de prasugrel con estabilidad mejorada |
EP11174395A EP2409685A3 (en) | 2010-07-19 | 2011-07-18 | Orally-disintegrating formulations of prasugrel |
ES11174408.2T ES2465998T3 (es) | 2010-07-19 | 2011-07-18 | Formulaciones de comprimidos de prasugrel |
EP11174408.2A EP2409689B1 (en) | 2010-07-19 | 2011-07-18 | Prasugrel tablet formulations |
EP11174384.5A EP2409701B1 (en) | 2010-07-19 | 2011-07-18 | Prasugrel granules with improved stability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/05900A TR201005900A1 (tr) | 2010-07-19 | 2010-07-19 | Geliştirilmiş stabiliteye sahip prasugrel granülleri. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201005900A1 true TR201005900A1 (tr) | 2012-02-21 |
Family
ID=43530826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2010/05900A TR201005900A1 (tr) | 2010-07-19 | 2010-07-19 | Geliştirilmiş stabiliteye sahip prasugrel granülleri. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2409701B1 (tr) |
ES (1) | ES2467934T3 (tr) |
TR (1) | TR201005900A1 (tr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016122421A1 (en) | 2015-01-29 | 2016-08-04 | Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. | Stable pharmaceutical compositions containing prasugrel base |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2100607A1 (en) * | 2006-12-07 | 2009-09-16 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
US20090291138A1 (en) * | 2006-12-07 | 2009-11-26 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
EP2275087A1 (en) * | 2010-02-22 | 2011-01-19 | Helm AG | Prasugrel controlled release formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230762B1 (hu) | 2000-07-06 | 2018-03-28 | Daiichi Sankyo Company, Limited | Hidropiridin-származékok maleát addíciós sója |
TWI318571B (en) | 2005-06-10 | 2009-12-21 | Lilly Co Eli | Formulation of a thienopyridine platelet aggregation inhibitor |
WO2008140459A1 (en) | 2007-05-16 | 2008-11-20 | Fmc Corporation | Solid form |
EP2398468B1 (en) * | 2009-02-17 | 2016-11-30 | KRKA, D.D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
-
2010
- 2010-07-19 TR TR2010/05900A patent/TR201005900A1/tr unknown
-
2011
- 2011-07-18 ES ES11174384.5T patent/ES2467934T3/es active Active
- 2011-07-18 EP EP11174384.5A patent/EP2409701B1/en not_active Not-in-force
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2100607A1 (en) * | 2006-12-07 | 2009-09-16 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
US20090291138A1 (en) * | 2006-12-07 | 2009-11-26 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
EP2275087A1 (en) * | 2010-02-22 | 2011-01-19 | Helm AG | Prasugrel controlled release formulations |
Also Published As
Publication number | Publication date |
---|---|
ES2467934T3 (es) | 2014-06-13 |
EP2409701A1 (en) | 2012-01-25 |
EP2409701B1 (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201905226T4 (tr) | Bir gecikmeli salım ilaç formülasyonu. | |
FR2962442B1 (fr) | Composition stable de 2,3,3,3-tetrafluoropropene | |
BR112013015124A2 (pt) | composto, composição fotocrômica e artigo fotocrômico | |
BR112013014816A2 (pt) | composto, composição fotocrômica e artigo fotocrômico | |
IL227963A0 (en) | History History of cytotoxic benzodiazepines, preparations containing them and their uses | |
BRPI1009824A2 (pt) | dispersão sólida e forma farmacêutica sólida. | |
DK3222272T3 (da) | Farmaceutisk sammensætning med carbetocin | |
BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
BR112013014361A2 (pt) | forma de dosagem | |
EP2803707A4 (en) | COATING COMPOSITION, POROUS FILM, LIGHT TRANSPARENCY AND ORGANIC ELECTROLUMINESCENT ELEMENT | |
CO6801782A2 (es) | Composiciones de recubrimiento con propiedades antocorrósión | |
EP2678320A4 (en) | FLUMAZENIL COMPLEXES, COMPOSITIONS THEREOF AND USES THEREOF | |
BR112014005242A2 (pt) | composições de nanopartículas com pertídeos | |
BR112013011627A2 (pt) | composição de inibição da corrosão | |
BR112013016037A2 (pt) | composição em gel. | |
BR112012031855A2 (pt) | composição e artigo | |
BR112013008464A2 (pt) | composição de revestimento. | |
IT1400425B1 (it) | Modified snrnas for use in therapy. | |
BR112012017673A2 (pt) | contrução de artigo de bagagem aperfeiçoado | |
FR2959229B1 (fr) | Derives peptidiques, leur preparation et leurs utilisations | |
BR112012027165A2 (pt) | composição e artigo | |
BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
BR112015009718A2 (pt) | composição de matéria e artigo. | |
BR112013009033A2 (pt) | composições de revestimento com propriedades anti-corrosão | |
FR2955770B1 (fr) | Composition cosmetique. |